Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading down 5 points (0.0%) at 16,932 as of Tuesday, June 24, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,934 issues advancing vs. 1,059 declining with 170 unchanged.

The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was

ResMed

(

RMD

), up 0.8%. Top gainers within the industry include

Grifols

(

GRFS

), up 1.8%,

CR Bard

(

BCR

), up 0.9%,

St Jude Medical

(

STJ

), up 0.6% and

Boston Scientific

(

BSX

), up 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3.

Smith & Nephew

(

SNN

) is one of the companies pushing the Health Services industry lower today. As of noon trading, Smith & Nephew is down $2.05 (-2.3%) to $88.86 on average volume. Thus far, 169,278 shares of Smith & Nephew exchanged hands as compared to its average daily volume of 229,300 shares. The stock has ranged in price between $88.83-$89.60 after having opened the day at $89.47 as compared to the previous trading day's close of $90.91.

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. Smith & Nephew has a market cap of $16.5 billion and is part of the health care sector. Shares are up 26.7% year-to-date as of the close of trading on Monday. Currently there are 5 analysts that rate Smith & Nephew a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates

Smith & Nephew

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Smith & Nephew Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading,

Centene

(

CNC

) is down $1.26 (-1.6%) to $74.98 on light volume. Thus far, 259,950 shares of Centene exchanged hands as compared to its average daily volume of 697,500 shares. The stock has ranged in price between $74.76-$76.28 after having opened the day at $76.28 as compared to the previous trading day's close of $76.24.

Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Managed Care and Specialty Services. Centene has a market cap of $4.4 billion and is part of the health care sector. Shares are up 29.3% year-to-date as of the close of trading on Monday. Currently there are 8 analysts that rate Centene a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Centene

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

Centene Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading,

Tenet Healthcare

(

THC

) is down $0.76 (-1.5%) to $48.71 on light volume. Thus far, 423,502 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $48.55-$49.36 after having opened the day at $49.32 as compared to the previous trading day's close of $49.47.

Tenet Healthcare Corporation, an investor-owned health care services company, primarily operates acute care hospitals and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.8 billion and is part of the health care sector. Shares are up 17.4% year-to-date as of the close of trading on Monday. Currently there are 7 analysts that rate Tenet Healthcare a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Tenet Healthcare

as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and poor profit margins. Get the full

Tenet Healthcare Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null